Keyphrases
Overall Survival
94%
Acute Lymphoblastic Leukemia
92%
Non-Hodgkin Lymphoma
80%
Lymphoma
76%
AIDS/HIV
66%
Leukemia Patients
59%
Complete Remission
55%
Prognostic Factors
45%
Prognostic Significance
44%
Chemotherapy
44%
Human Immunodeficiency Virus Infection
42%
Highly Active Antiretroviral Therapy (HAART)
41%
Adult Patients
40%
Chronic Myeloid Leukemia
40%
Older Adults
35%
HIV Patients
33%
High Risk
32%
Lymphoma Patients
31%
Bone Marrow
31%
BCP-ALL
30%
Survival Probability
29%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
28%
Disease-free Survival
28%
Advanced Stage
26%
Complete Response
26%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
26%
Hematopoietic Stem Cell Transplantation
26%
HIV Infection
25%
Splenectomy
25%
Progression-free Survival
24%
Biological Characteristics
24%
Radiotherapy
23%
Confidence Interval
22%
Diffuse Large B-cell Lymphoma (DLBCL)
22%
Response to Treatment
22%
Adult Acute Lymphoblastic Leukemia
22%
Minimal Residual Disease
20%
Clinical Features
20%
Elderly Patients
20%
Splenic Function
20%
Primary Intestinal Lymphangiectasia
20%
Intensive Care Unit
20%
Pediatric Inspired
20%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
20%
Conjunctiva
20%
MALT Lymphoma
20%
Flow Cytometry
20%
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
20%
Multivariate Analysis
19%
Older Patients
19%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
B Cell
77%
Human Immunodeficiency Virus
75%
Non-Hodgkin Lymphoma
75%
Overall Survival
74%
Chemotherapy
62%
Human Immunodeficiency Virus Infection
58%
Prognostic Factor
46%
Precursor
42%
Radiation Therapy
37%
Philadelphia 1 Chromosome
32%
Highly Active Antiretroviral Therapy
30%
Diseases
29%
Lymphocyte
27%
Splenectomy
25%
Spontaneous Remission
23%
Patient with Human Immunodeficiency Virus
22%
MALT Lymphoma
21%
Hematologic Malignancy
21%
Cancer
21%
Diffuse Large B-Cell Lymphoma
20%
Acquired Immune Deficiency Syndrome
20%
Disease Free Survival
20%
Intensive Care Unit
20%
Flow Cytometry
20%
Gastrointestinal Lymphoma
20%
Elderly Patient
20%
Hodgkin's Lymphoma
20%
Mucosa-Associated Lymphoid Tissue
20%
Pediatrics
20%
Survival Rate
19%
Bone Marrow Transplantation
17%
Bone Marrow Biopsy
17%
Diagnosis
17%
Progression Free Survival
17%
Minimal Residual Disease
16%
B Symptoms
15%
Hematopoietic Stem Cell Transplantation
15%
Infection
15%
Rituximab
15%
Lung Lavage
15%
Leukemia
15%
CHOP
14%
Multivariate Analysis
14%
Epstein Barr Virus
13%
Acute Myeloid Leukemia
13%
Morphology
13%
Leukocyte
13%
Antiretroviral Therapy
12%
Vincristine
12%
